SMYD3 and ovarian carcinoma: In ovarian cancer spheroids, SMYD3 was found bind to H3K4me3 at the ITGB6 and ITGAM promoter regions to upregulate the expression of ITGB6 and ITGAM, which was verified to enhance the invasion and adhesion of ovarian cancer spheroids (7).